Cyclin-dependent kinase 4 inhibitor a and tumor

被引：0
|
作者：
Gong, Z. [1 ]
Fu, J. [1 ]
机构：
[1] Medical Genetics Department, Second Military Medical University, Shanghai 200433, China
来源：
Chinese Journal of Medical Genetics | 2001年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tumors
引用
收藏
页码：219 / 221
相关论文
共 50 条
  • [41] Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits
    Eva-Maria D. Nielsen
    Lars Hansen
    Trine Stissing
    Keiko Yanagisawa
    Knut Borch-Johnsen
    Pernille Poulsen
    Allan Vaag
    Torben Hansen
    Oluf Pedersen
    Journal of Molecular Medicine, 2005, 83 : 353 - 361
  • [42] Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits
    Nielsen, EMD
    Hansen, L
    Stissing, T
    Yanagisawa, K
    Borch-Johnsen, K
    Poulsen, P
    Vaag, A
    Hansen, T
    Pedersen, O
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (05): : 353 - 361
  • [43] Concomitant presence of p16 cyclin-dependent kinase 4 and cyclin D cyclin-dependent kinase 4 complexes in LNCaP prostatic cancer cell line
    Itoh, N
    Kakehi, Y
    Akao, T
    Kinoshita, H
    Okada, Y
    Yoshida, O
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (03): : 229 - 233
  • [44] Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials
    Senderowicz, AM
    INVESTIGATIONAL NEW DRUGS, 1999, 17 (03) : 313 - 320
  • [45] The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase
    Kaiser, A
    Nishi, K
    Gorin, FA
    Walsh, DA
    Bradbury, EM
    Schnier, JB
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 386 (02) : 179 - 187
  • [46] SNS-032. Cyclin-dependent kinase inhibitor, Oncolytic.
    Vasiliou, S.
    DRUGS OF THE FUTURE, 2008, 33 (11) : 932 - 937
  • [47] The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics
    Schutte, B
    Nieland, L
    vanEngeland, M
    Henfling, MER
    Meijer, L
    Ramaekers, FCS
    EXPERIMENTAL CELL RESEARCH, 1997, 236 (01) : 4 - 15
  • [48] Synthesis and configuration of the cyclin-dependent kinase inhibitor roscovitine and its enantiomer
    Wang, SD
    McClue, SJ
    Ferguson, JR
    Hull, JD
    Stokes, S
    Parsons, S
    Westwood, R
    Fischer, PM
    TETRAHEDRON-ASYMMETRY, 2001, 12 (20) : 2891 - 2894
  • [49] Structure of the cyclin-dependent kinase inhibitor p19(Ink4d)
    Luh, FY
    Archer, SJ
    Domaille, PJ
    Smith, BO
    Owen, D
    Brotherton, DH
    Raine, ARC
    Xu, X
    Brizuela, L
    Brenner, SL
    Laue, ED
    NATURE, 1997, 389 (6654) : 999 - 1003
  • [50] Phase I study of palbociclib, a cyclin-dependent kinase 4/6 inhibitor, in Japanese patients
    Tamura, Kenji
    Mukai, Hirofumi
    Naito, Yoichi
    Yonemori, Kan
    Kodaira, Makoto
    Tanabe, Yuko
    Yamamoto, Noboru
    Osera, Shozo
    Sasaki, Masaoki
    Mori, Yuko
    Hashigaki, Satoshi
    Nagasawa, Takashi
    Umeyama, Yoshiko
    Yoshino, Takayuki
    CANCER SCIENCE, 2016, 107 (06) : 755 - 763
12345